Each year at the JP Morgan Healthcare Conference, life sciences leaders congregate in San Francisco’s Union Square to network, make deals, and give updates on their work.
In recent years, no force is shaping the pharma industry as dramatically as government policy. In the US, EU, UK, and beyond, dramatic policy shifts shape everything from drug pricing to pharma marketing to research and development. Keep up with those shifts as they happen, right here.
The annual conference of the Biotechnology Innovation Organization (BIO) is always an anticipated gathering where pharma and biotech leaders and policymakers meet to discuss the challenges facing their industry.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.